Flavivirus encephalitis: Pathological aspects of mouse and other animal models

Veterinary Pathology

Volumn 47, Issue 5, 2010, Pages 806-818

  Kimura, Takashi ^a   Sasaki, M ^a   Okumura, M ^a   Kim, E ^a   Sawa, H ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

experimental animal models; Flavivirus; histopathology; Japanese encephalitis virus; mice; mosquito borne encephalitis; West Nile virus

Indexed keywords

ANIMAL; ARTICLE; DISEASE MODEL; HUMAN; IMMUNOLOGY; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; MOUSE; PATHOLOGY; VIROLOGY; WEST NILE FEVER; WEST NILE FLAVIVIRUS;

ANIMALS; DISEASE MODELS, ANIMAL; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; HUMANS; MICE; WEST NILE FEVER; WEST NILE VIRUS;

ANIMALIA; ARTHROPODA; FLAVIVIRUS; JAPANESE ENCEPHALITIS VIRUS; MACACA; MUS; RODENTIA; WEST NILE VIRUS;

EID: 78649266548     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985810372507     Document Type: Article

References (128)

1. Armah HB, Wang G., Omalu BI, Tesh RB, Gyure KA, Chute DJ, Smith RD, Dulai P., Vinters HV, Kleinschmidt-DeMasters BK, Wiley CA: Systemic distribution of West Nile virus infection: postmortem immunohistochemical study of six cases. Brain Pathol 17:354-362, 2007.
2. Arroyo J., Miller C., Catalan J., Myers GA, Ratterree MS, Trent DW, Monath TP: ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy. J Virol 78:12497-12507, 2004.
3. Austgen LE, Bowen RA, Bunning ML, Davis BS, Mitchell CJ, Chang GJ: Experimental infection of cats and dogs with West Nile virus. Emerg Infect Dis 10:82-86, 2004.
4. Blok J., McWilliam SM, Butler HC, Gibbs AJ, Weiller G., Herring BL, Hemsley AC, Aaskov JG, Yoksan S., Bhamarapravati N.: Comparison of a dengue-2 virus and its candidate vaccine derivative: sequence relationships with the flaviviruses and other viruses. Virology 187:573-590, 1992.
5. Brenner W., Storch G., Buller R., Vij R., Devine S., DiPersio J.: West Nile virus encephalopathy in an allogeneic stem cell transplant recipient: use of quantitative PCR for diagnosis and assessment of viral clearance. Bone Marrow Transplant 36:369-370, 2005.
6. Brown AN, Kent KA, Bennett CJ, Bernard KA: Tissue tropism and neuroinvasion of West Nile virus do not differ for two mouse strains with different survival rates. Virology 368: 422-430, 2007.
7. Buescher EL, Scherer WF: Ecologic studies of Japanese encephalitis virus in Japan. IX: Epidemiologic correlations and conclusions. Am J Trop Med Hyg 8:719-722, 1959.
8. Bunning ML, Bowen RA, Cropp CB, Sullivan KG, Davis BS, Komar N, Godsey MS, Baker D, Hettler DL, Holmes DA, Biggerstaff BJ, Mitchell CJ: Experimental infection of horses with West Nile virus. Emerg Infect Dis 8:380-386, 2002.
9. Byrne SN, Halliday GM, Johnston LJ, King NJ: Interleukin-1 beta but not tumor necrosis factor is involved in West Nile virus-induced Langerhans cell migration from the skin in C57BL/6 mice. J Invest Dermatol 117:702-709, 2001.
10. Calisher CH, Karabatsos N., Dalrymple JM, Shope RE, Porterfield JS, Westaway EG, Brandt WE: Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol 70:37-43, 1989.
11. Cao JX, Ni H., Wills MR, Campbell GA, Sil BK, Ryman KD, Kitchen I., Barrett AD: Passage of Japanese encephalitis virus in HeLa cells results in attenuation of virulence in mice. J Gen Virol 76:2757-2764, 1995.
12. Ceausu E., Erscoiu S., Calistru P., Ispas D., Dorobat O., Homos M., Barbulescu C., Cojocaru I., Simion CV, Cristea C., Oprea C., Dumitrescu C., Duiculescu D., Marcu I., Mociornita C., Stoicev T., Zolotusca I., Calomfirescu C., Rusu R., Hodrea R., Geamai S., Paun L.: Clinical manifestations in the West Nile virus outbreak. Rom J Virol 48:3-11, 1997.
13. Chambers TJ, Diamond MS: Pathogenesis of flavivirus encephalitis. Adv Virus Res 60:273-342, 2003.
14. Charlier N., Leyssen P., De Clercq E., Neyts J.: Rodent models for the study of therapy against flavivirus infections. Antiviral Res 63:67-77, 2004.
15. Chen LK, Lin YL, Liao CL, Lin CG, Huang YL, Yeh CT, Lai SC, Jan JT, Chin C.: Generation and characterization of organ-tropism mutants of Japanese encephalitis virus in vivo and in vitro. Virology 223:79-88, 1996.
16. Chung CC, Lee SS, Chen YS, Tsai HC, Wann SR, Kao CH, Liu YC: Acute flaccid paralysis as an unusual presenting symptom of Japanese encephalitis: a case report and review of the literature. Infection 35:30-32, 2007.
17. Darnell MB, Koprowski H., Lagerspetz K.: Genetically determined resistance to infection with group B arboviruses. I. Distribution of the resistance gene among various mouse populations and characteristics of gene expression in vivo. J Infect Dis 129:240-247, 1974.
18. Das S., Laxminarayana SV, Chandra N., Ravi V., Desai A.: Heat shock protein 70 on Neuro2a cells is a putative receptor for Japanese encephalitis virus. Virology 385:47-57, 2009.
19. Dauphin G., Zientara S., Zeller H., Murgue B.: West Nile: worldwide current situation in animals and humans. Comp Immunol Microbiol Infect Dis 27:343-355, 2004.
20. De Madrid AT, Porterfield JS: The flaviviruses (group B arboviruses): a cross-neutralization study. J Gen Virol 23:91-96, 1974.
21. Desai A., Shankar SK, Ravi V., Chandramuki A., Gourie-Devi M.: Japanese encephalitis virus antigen in the human brain and its topographic distribution. Acta Neuropathol 89:368-373, 1995.
22. Diamond MS: Virus and host determinants of West Nile virus pathogenesis. PLoS Pathog 5:e1000452, 2009.
23. Diamond MS, Shrestha B., Marri A., Mahan D., Engle M.: B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol 77:2578-2586, 2003.
24. Diamond MS, Sitati EM, Friend LD, Higgs S., Shrestha B., Engle M.: A critical role for induced IgM in the protection against West Nile virus infection. J Exp Med 198:1853-1862, 2003.
25. Dickerson RB, Newton JR, Hansen JE: Diagnosis and immediate prognosis of Japanese B encephalitis: observations based on more than 200 patients with detailed analysis of 65 serologically confirmed cases. Am J Med 12:277-288, 1952.
26. Duffy CE: Japanese B encephalitis in the rat. Proc Soc Exp Biol Med 76:566-569, 1951.
27. Edgren DC, Palladino VS, Arnold A.: Japanese B and mumps encephalitis: a clinicopathological report of simultaneous outbreaks on the island of Guam. Am J Trop Med Hyg 7:471-480, 1958.
28. Eldadah AH, Nathanson N.: Pathogenesis of West Nile virus encepahlitis in mice and rats. II: Virus multiplication, evolution of immunofluorescence, and development of histological lesions in the brain. Am J Epidemiol 86:776-790, 1967.
29. Fratkin JD, Leis AA, Stokic DS, Slavinski SA, Geiss RW: Spinal cord neuropathology in human West Nile virus infection. Arch Pathol Lab Med 128:533-537, 2004.
30. Fujii Y., Kitaura K., Nakamichi K., Takasaki T., Suzuki R., Kurane I.: Accumulation of T-cells with selected T-cell receptors in the brains of Japanese encephalitis virus-infected mice. Jpn J Infect Dis 61:40-48, 2008.
31. Garcia-Tapia D., Hassett DE, Mitchell WJ Jr, Johnson GC, Kleiboeker SB: West Nile virus encephalitis: sequential histopathological and immunological events in a murine model of infection. J Neurovirol 13:130-138, 2007.
32. Garcia-Tapia D., Loiacono CM, Kleiboeker SB: Replication of West Nile virus in equine peripheral blood mononuclear cells. Vet Immunol Immunopathol 110:229-244, 2006.
33. German AC, Myint KS, Mai NT, Pomeroy I., Phu NH, Tzartos J., Winter P., Collett J., Farrar J., Barrett A., Kipar A., Esiri MM, Solomon T.: A preliminary neuropathological study of Japanese encephalitis in humans and a mouse model. Trans R Soc Trop Med Hyg 100:1135-1145, 2006.
34. Ghosh SN, Goverdhan MK, Sathe PS, Chelliah SC, Naik SV, Godbole PV, Banerjee K.: Protective effect of 6-MFA, a fungal interferon inducer against Japanese encephalitis virus in bonnet macaques. Indian J Med Res 91:408-413, 1990.
35. Ghoshal A., Das S., Ghosh S., Mishra MK, Sharma V., Koli P., Sen E., Basu A.: Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis. Glia 55:483-496, 2007.
36. Glass WG, Lim JK, Cholera R., Pletnev AG, Gao JL, Murphy PM: Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J Exp Med 202:1087-1098, 2005.
37. Goverdhan MK, Kulkarni AB, Gupta AK, Tupe CD, Rodrigues JJ: Two-way cross-protection between West Nile and Japanese encephalitis viruses in bonnet macaques. Acta Virol 36:277-283, 1992.
38. Grossberg SE, Scherer WF: The effect of host age, virus dose and route of inoculation on inapparent infection in mice with Japanese encephalitis virus. Proc Soc Exp Biol Med 123:118-124, 1966.
39. Guarner J., Shieh WJ, Hunter S., Paddock CD, Morken T., Campbell GL, Marfin AA, Zaki SR: Clinicopathologic study and laboratory diagnosis of 23 cases with West Nile virus encephalomyelitis. Hum Pathol 35:983-990, 2004.
40. Gubler D., Kuno G., Markoff L.: Flaviviruses. In: Fields Virology, ed. Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, 5th ed., pp. 1153-1252. Lippincott Williams & Wilkins, Philadelphia, PA, 2007.
41. Harrington DG, Hilmas DE, Elwell MR, Whitmire RE, Stephen EL: Intranasal infection of monkeys with Japanese encephalitis virus: clinical response and treatment with a nuclease-resistant derivative of poly(I)Ä
42. Hase T., Dubois DR, Summers PL: Comparative study of mouse brains infected with Japanese encephalitis virus by intracerebral or intraperitoneal inoculation. Int J Exp Pathol 71:857-869, 1990.
43. Hayes EB, Komar N., Nasci RS, Montgomery SP, O'Leary DR, Campbell GL: Epidemiology and transmission dynamics of West Nile virus disease. Emerg Infect Dis 11:1167-1173, 2005.
44. Heinz FX: Epitope mapping of flavivirus glycoproteins. Adv Virus Res 31:103-168, 1986.
45. Huang CH: Studies of virus factors as causes of inapparent infection in Japanese B encephalitis: virus strains, viraemia, stability to heat and infective dosage. Acta Virol 1:36-45, 1957.
46. Huang CH: Studies on host factors in inapparent infection with Japanese B encephalitis: influence of age, nutrition and luminalinduced sleep on the course of infection in mice. Acta Virol 1:83-91, 1957.
47. Huang CH, Wong C.: Relation of the peripheral multiplication of Japanese B encephalitis virus to the pathogenesis of the infection in mice. Acta Virol 7:322-330, 1963.
48. Johnson RT, Burke DS, Elwell M., Leake CJ, Nisalak A., Hoke CH, Lorsomrudee W.: Japanese encephalitis: immunocytochemical studies of viral antigen and inflammatory cells in fatal cases. Ann Neurol 18:567-573, 1985.
49. Johnston LJ, Halliday GM, King NJ: Langerhans cells migrate to local lymph nodes following cutaneous infection with an arbovirus. J Invest Dermatol 114:560-568, 2000.
50. Johnston LJ, Halliday GM, King NJ: Phenotypic changes in Langerhans' cells after infection with arboviruses: a role in the immune response to epidermally acquired viral infection? J Virol 70:4761-4766, 1996.
51. Kimura T., Kimura-Kuroda J., Nagashima K., Yasui K.: Analysis of virus-cell binding characteristics on the determination of Japanese encephalitis virus susceptibility. Arch Virol 139: 239-251, 1994.
52. Kimura-Kuroda J., Ichikawa M., Ogata A., Nagashima K., Yasui K.: Specific tropism of Japanese encephalitis virus for developing neurons in primary rat brain culture. Arch Virol 130:477-484, 1993.
53. Klein RS, Lin E., Zhang B., Luster AD, Tollett J., Samuel MA, Engle M., Diamond MS: Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J Virol 79:11457-11466, 2005.
54. Kleinschmidt-DeMasters BK, Marder BA, Levi ME, Laird SP, McNutt JT, Escott EJ, Everson GT, Tyler KL: Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features. Arch Neurol 61:1210-1220, 2004.
55. Komar N., Langevin S., Hinten S., Nemeth N., Edwards E., Hettler D., Davis B., Bowen R., Bunning M.: Experimental infection of North American birds with the New York 1999 strain of West Nile virus. Emerg Infect Dis 9:311-322, 2003.
56. Lee GC, Grayston JT, Wang SP: Protective studies in mice and monkeys with an inactivated Japanese encephalitis virus vaccine grown in hamster diploid cell culture. Proc Soc Exp Biol Med 125:803-808, 1967.
57. Lewis JA, Chang GJ, Lanciotti RS, Kinney RM, Mayer LW, Trent DW: Phylogenetic relationships of dengue-2 viruses. Virology 197:216-224, 1993.
58. Lieberman MM, Nerurkar VR, Luo H., Cropp B, Carrion R Jr, de la Garza M, Coller BA, Clements D, Ogata S, Wong T, Martyak T, Weeks-Levy C: Immunogenicity and protective efficacy of a recombinant subunit West Nile virus vaccine in rhesus monkeys. Clin Vaccine Immunol 16:1332-1337, 2009.
59. Lindenbach BD, Thiel H-J., Rice CM: Flaviviridae: the viruses and their replication. In: Fields Virology, ed. Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, 5th ed., pp. 1101-1152. Lippincott Williams & Wilkins, Philadelphia, PA, 2007.
60. Mackenzie JS, Gubler DJ, Petersen LR: Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 10:S98-S109, 2004.
61. Malkova D.: Role of free cells in the lymph and blood vessels during viraemia in animals experimentally infected with tick-borne encephalitis virus. II: Virus bound in vivo to the cellular blood component in mice. Acta Virol 11:317-320, 1967.
62. Malkova D.: The role of the lymphatic system in experimental infection with tick-borne encephalitis. I: The tick-borne encephalitis virus in the lymph and blood of experimentally infected sheep. Acta Virol 4:233-240, 1960.
63. Mandl CW, Holzmann H., Kunz C., Heinz FX: Complete genomic sequence of Powassan virus: evaluation of genetic elements in tick-borne versus mosquito-borne flaviviruses. Virology 194:173-184, 1993.
64. Martin DA, Muth DA, Brown T., Johnson AJ, Karabatsos N., Roehrig JT: Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol 38:1823-1826, 2000.
65. Mashimo T., Lucas M., Simon-Chazottes D., Frenkiel MP, Montagutelli X., Ceccaldi PE, Deubel V., Guenet JL, Despres P.: A nonsense mutation in the gene encoding 2′-5′-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc Natl Acad Sci U S A 99:11311-11316, 2002.
66. Mathur A., Arora KL, Chaturvedi UC: Transplacental Japanese encephalitis virus (JEV) infection in mice during consecutive pregnancies. J Gen Virol 59:213-217, 1982.
67. Mathur A., Arora KL, Rawat S., Chaturvedi UC: Persistence, latency and reactivation of Japanese encephalitis virus infection in mice. J Gen Virol 67:381-385, 1986.
68. Mathur A., Bharadwaj M., Kulshreshtha R., Rawat S., Jain A., Chaturvedi UC: Immunopathological study of spleen during Japanese encephalitis virus infection in mice. Br J Exp Pathol 69:423-432, 1988.
69. Mathur A., Kulshreshtha R., Chaturvedi UC: Evidence for latency of Japanese encephalitis virus in T lymphocytes. J Gen Virol 70:461-465, 1989.
70. Miura K., Goto N., Suzuki H., Fujisaki Y.: Strain difference of mouse in susceptibility to Japanese encephalitis virus infection. Jikken Dobutsu 37:365-373, 1988.
71. Miura T.: A new method for a potency test of Japanese encephalitis vaccine: direct challenge method on suckling mice by subcutaneous inoculation. Bull World Health Organ 43:553-557, 1970.
72. Monath TP, Cropp CB, Harrison AK: Mode of entry of a neuro-tropic arbovirus into the central nervous system: reinvestigation of an old controversy. Lab Invest 48:399-410, 1983.
73. Monath TP, Levenbook I., Soike K., Zhang ZX, Ratterree M., Draper K., Barrett AD, Nichols R., Weltzin R., Arroyo J., Guirakhoo F.: Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys. J Virol 74:1742-1751, 2000.
74. Monath TP, Soike K., Levenbook I., Zhang ZX, Arroyo J., Delagrave S., Myers G., Barrett AD, Shope RE, Ratterree M., Chambers TJ, Guirakhoo F.: Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates. Vaccine 17:1869-1882, 1999.
75. Morris JA, O'Connor JR, Smadel JE: Infection and immunity patterns in monkeys injected with viruses of Russian spring-summer and Japanese encephalitis. Am J Hyg 62:327-341, 1955.
76. Murgue B., Zeller H., Deubel V.: The ecology and epidemiology of West Nile virus in Africa, Europe and Asia. Curr Top Microbiol Immunol 267:195-221, 2002.
77. Myint KS, Raengsakulrach B., Young GD, Gettayacamin M., Ferguson LM, Innis BL, Hoke CH Jr, Vaughn DW: Production of lethal infection that resembles fatal human disease by intranasal inoculation of macaques with Japanese encephalitis virus. Am J Trop Med Hyg 60:338-342, 1999.
78. Nalca A., Fellows PF, Whitehouse CA: Vaccines and animal models for arboviral encephalitides. Antiviral Res 60:153-174, 2003.
79. Nathanson N.: Pathogenesis. In: St. Louis Encephalitis, ed. Monath TP, pp. 201-236. American Public Health Association, Washington, DC, 1980.
80. Nemeth NM, Beckett S., Edwards E., Klenk K., Komar N.: Avian mortality surveillance for West Nile virus in Colorado. Am J Trop Med Hyg 76:431-437, 2007.
81. O'Leary DR, Marfin AA, Montgomery SP, Kipp AM, Lehman JA, Biggerstaff BJ, Elko VL, Collins PD, Jones JE, Campbell GL: The epidemic of West Nile virus in the United States, 2002. Vector Borne Zoonotic Dis 4:61-70, 2004.
82. Ogata A., Nagashima K., Hall WW, Ichikawa M., Kimura-Kuroda J., Yasui K.: Japanese encephalitis virus neurotropism is dependent on the degree of neuronal maturity. J Virol 65:880-886, 1991.
83. Ogata A., Tashiro K., Nukuzuma S., Nagashima K., Hall WW: A rat model of Parkinson's disease induced by Japanese encephalitis virus. J Neurovirol 3:141-147, 1997.
84. Ølberg RA, Barker IK, Crawshaw GJ, Bertelsen MF, Drebot MA, Andonova M.: West Nile virus encephalitis in a Barbary macaque (Macaca sylvanus). Emerg Infect Dis 10:712-714, 2004.
85. Omalu BI, Shakir AA, Wang G., Lipkin WI, Wiley CA: Fatal fulminant pan-meningo-polioencephalitis due to West Nile virus. Brain Pathol 13:465-472, 2003.
86. Paddock CD, Nicholson WL, Bhatnagar J., Goldsmith CS, Greer PW, Hayes EB, Risko JA, Henderson C., Blackmore CG, Lanciotti RS, Campbell GL, Zaki SR: Fatal hemorrhagic fever caused by West Nile virus in the United States. Clin Infect Dis 42:1527-1535, 2006.
87. Perelygin AA, Scherbik SV, Zhulin IB, Stockman BM, Li Y., Brinton MA: Positional cloning of the murine flavivirus resistance gene. Proc Natl Acad Sci U S A 99:9322-9327, 2002.
88. Petersen LR, Marfin AA: West Nile virus: a primer for the clinician. Ann Intern Med 137:173-179, 2002.
89. Petersen LR, Roehrig JT: West Nile virus: a reemerging global pathogen. Emerg Infect Dis 7:611-614, 2001.
90. Pletnev AG, Claire MS, Elkins R., Speicher J., Murphy BR, Chanock RM: Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus. Virology 314:190-195, 2003.
91. Pogodina VV, Frolova MP, Malenko GV, Fokina GI, Koreshkova GV, Kiseleva LL, Bochkova NG, Ralph NM: Study on West Nile virus persistence in monkeys. Arch Virol 75:71-86, 1983.
92. Pradhan S., Pandey N., Shashank S., Gupta RK, Mathur A.: Parkinsonism due to predominant involvement of substantia nigra in Japanese encephalitis. Neurology 53:1781-1786, 1999.
93. Raengsakulrach B., Nisalak A., Gettayacamin M., Thirawuth V., Young GD, Myint KS, Ferguson LM, Hoke CH Jr, Innis BL, Vaughn DW: An intranasal challenge model for testing Japanese encephalitis vaccines in rhesus monkeys. Am J Trop Med Hyg 60:329-337, 1999.
94. Ratterree MS, Gutierrez RA, Travassos da Rosa AP, Dille BJ, Beasley DW, Bohm RP, Desai SM, Didier PJ, Bikenmeyer LG, Dawson GJ, Leary TP, Schochetman G., Phillippi-Falkenstein K., Arroyo J., Barrett AD, Tesh RB: Experimental infection of rhesus macaques with West Nile virus: level and duration of viremia and kinetics of the antibody response after infection. J Infect Dis 189:669-676, 2004.
95. Ren J., Ding T., Zhang W., Song J., Ma W.: Does Japanese encephalitis virus share the same cellular receptor with other mosquito-borne flaviviruses on the C6/36 mosquito cells? Virol J 4:83, 2007.
96. Samuel MA, Diamond MS: Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J Virol 80:9349-9360, 2006.
97. Samuel MA, Wang H., Siddharthan V., Morrey JD, Diamond MS: Axonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysis. Proc Natl Acad Sci U S A 104:17140-17145, 2007.
98. Sangster MY, Heliams DB, MacKenzie JS, Shellam GR: Genetic studies of flavivirus resistance in inbred strains derived from wild mice: evidence for a new resistance allele at the flavivirus resistance locus (Flv). J Virol 67:340-347, 1993.
99. Saxena SK, Mathur A., Srivastava RC: Induction of nitric oxide synthase during Japanese encephalitis virus infection: evidence of protective role. Arch Biochem Biophys 391:1-7, 2001.
100. Scherbik SV, Kluetzman K., Perelygin AA, Brinton MA: Knock-in of the Oas1b(r) allele into a flavivirus-induced disease susceptible mouse generates the resistant phenotype. Virology 368:232-237, 2007.
101. Sejvar JJ, Haddad MB, Tierney BC, Campbell GL, Marfin AA, Van Gerpen JA, Fleischauer A., Leis AA, Stokic DS, Petersen LR: Neurologic manifestations and outcome of West Nile virus infection. JAMA 290:511-515, 2003.
102. Senne DA, Pedersen JC, Hutto DL, Taylor WD, Schmitt BJ, Panigrahy B.: Pathogenicity of West Nile virus in chickens. Avian Dis 44:642-649, 2000.
103. Shirato K., Kimura T., Mizutani T., Kariwa H., Takashima I.: Different chemokine expression in lethal and non-lethal murine West Nile virus infection. J Med Virol 74:507-513, 2004.
104. Shirato K., Miyoshi H., Goto A., Ako Y., Ueki T., Kariwa H., Takashima I.: Viral envelope protein glycosylation is a molecular determinant of the neuroinvasiveness of the New York strain of West Nile virus. J Gen Virol 85:3637-3645, 2004.
105. Shrestha B., Diamond MS: Role of CD8+ T cells in control of West Nile virus infection. J Virol 78:8312-8321, 2004.
106. Shrestha B., Gottlieb D., Diamond MS: Infection and injury of neurons by West Nile encephalitis virus. J Virol 77:13203-13213, 2003.
107. Shrestha B., Samuel MA, Diamond MS: CD8+ T cells require perforin to clear West Nile virus from infected neurons. J Virol 80:119-129, 2006.
108. Shrestha B., Wang T., Samuel MA, Whitby K., Craft J., Fikrig E., Diamond MS: Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. J Virol 80:5338-5348, 2006.
109. Sitati EM, Diamond MS: CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system. J Virol 80:12060-12069, 2006.
110. Smith RD, Konoplev S., DeCourten-Myers G., Brown T.: West Nile virus encephalitis with myositis and orchitis. Hum Pathol 35:254-258, 2004.
111. Solomon T., Kneen R., Dung NM, Khanh VC, Thuy TT, Ha DQ, Day NP, Nisalak A., Vaughn DW, White NJ: Poliomyelitis-like illness due to Japanese encephalitis virus. Lancet 351:1094-1097, 1998.
112. Solomon T., Vaughn DW: Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. In: Japanese Encephalitis and West Nile Viruses, ed. Mackenzie JS, Barrett ADT, Deubel V, pp. 171-194. Springer-Verlag, Berlin, 2002.
113. Steele KE, Linn MJ, Schoepp RJ, Komar N, Geisbert TW, Manduca RM, Calle PP, Raphael BL, Clippinger TL, Larsen T, Smith J, Lanciotti RS, Panella NA, McNamara TS: Pathology of fatal West Nile virus infections in native and exotic birds during the 1999 outbreak in New York City, New York. Vet Pathol 37:208-224, 2000.
114. Su CM, Liao CL, Lee YL, Lin YL: Highly sulfated forms of heparin sulfate are involved in japanese encephalitis virus infection. Virology 286:206-215, 2001.
115. Takasaki T., Yabe S., Nerome R., Ito M., Yamada K., Kurane I.: Partial protective effect of inactivated Japanese encephalitis vaccine on lethal West Nile virus infection in mice. Vaccine 21:4514-4518, 2003.
116. Teehee ML, Bunning ML, Stevens S., Bowen RA: Experimental infection of pigs with West Nile virus. Arch Virol 150:1249-1256, 2005.
117. Tesh RB, Siirin M., Guzman H., Travassos da Rosa AP, Wu X., Duan T., Lei H., Nunes MR, Xiao SY: Persistent West Nile virus infection in the golden hamster: studies on its mechanism and possible implications for other flavivirus infections. J Infect Dis 192:287-295, 2005.
118. Tyler KL, Gonzalez-Scarano F.: Viral diseases of the central nervous system: acute infection. In: Viral Pathogenesis, ed. Nathanson N, Ahmed R, Gonzalez-Scarano F, Griffin DE, Holmes KV, Murphy FARobinson HL, pp. 837-854. Lippincott-Raven, Philadelphia, PA, 1997.
119. Vaughn DW, Hoke CH Jr: The epidemiology of Japanese encephalitis: prospects for prevention. Epidemiol Rev 14:197-221, 1992.
120. Wang H., Siddharthan V., Hall JO, Morrey JD: West Nile virus preferentially transports along motor neuron axons after sciatic nerve injection of hamsters. J Neurovirol 15:293-299, 2009.
121. Wang Y., Lobigs M., Lee E., Mullbacher A.: CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis. J Virol 77:13323-13334, 2003.
122. Watson JT, Pertel PE, Jones RC, Siston AM, Paul WS, Austin CC, Gerber SI: Clinical characteristics and functional outcomes of West Nile fever. Ann Intern Med 141:360-365, 2004.
123. Weaver SC, Barrett AD: Transmission cycles, host range, evolution and emergence of arboviral disease. Nat Rev Microbiol 2:789-801, 2004.
124. Weingartl HM, Neufeld JL, Copps J., Marszal P.: Experimental West Nile virus infection in blue jays (Cyanocitta cristata) and crows (Corvus brachyrhynchos). Vet Pathol 41:362-370, 2004.
125. Wu SC, Chiang JR, Lin CW: Novel cell adhesive glycosaminoglycan-binding proteins of Japanese encephalitis virus. Biomacromolecules 5:2160-2164, 2004.
126. Wunschmann A., Shivers J., Carroll L., Bender J.: Pathological and immunohistochemical findings in American crows (Corvus brachyrhynchos) naturally infected with West Nile virus. J Vet Diagn Invest 16:329-333, 2004.
127. Xiao SY, Guzman H., Zhang H., Travassos da Rosa AP, Tesh RB: West Nile virus infection in the golden hamster (Mesocricetus auratus): a model for West Nile encephalitis. Emerg Infect Dis 7:714-721, 2001.
128. Zimmerman HM: The pathology of Japanese B encephalitis. Am J Pathol 22:965, 1946.